glp-1 sglt2 combination 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Brasil - Making a case

He also notes an opportunity to fortify foods

New York State Medicaid For patients with diabetes on NY Medicaid: Step therapy is required

Manufacturer Direct-to-Patient (Cash-Pay) Programs Both Novo Nordisk and Eli Lilly have launched direct-to-patient platforms offering GLP-1 medications at flat cash-pay rates significantly below the insurance list price

How long does GERD last on semaglutide

Coverage gaps, steep out-of-pocket costs, and payer-imposed roadblocks stall progress before treatment even begins, while stigma, fragmented care, and shifting patient perceptions chip away at long-term adherence

It discusses the emergence of new weight-loss drugs, including Novo Nordisks Wegovy and Ozempic and Eli Lillys Mounjaro, which have shown potential benefits beyond weight loss, such as reducing the risk of heart attack or stroke and possibly treating addiction